A 6-week remote rehab program for ICU survivors didn't significantly improve quality of life at 8 weeks, but showed meaningful gains by 6 months. The iRehab trial, published in JAMA, found the biggest benefits in patients who were on mechanical ventilation for 7 days or fewer. Secondary outcomes like fatigue, anxiety, and leg strength did improve earlier — suggesting the intervention has real, if delayed, value.
A large randomized trial called iRehab found that a 6-week remote, multicomponent rehabilitation program for ICU survivors did not significantly improve health-related quality of life at 8 weeks compared to standard care — but the picture improved considerably by 6 months. The study, presented at the American Thoracic Society International Conference and simultaneously published in JAMA, enrolled 429 adults across 52 U.K. hospitals who had required at least 48 hours of mechanical ventilation.
The intervention was delivered remotely via laptop or phone and included symptom management, psychological support, peer support, and individualized exercise — all tailored to each patient's needs by a multidisciplinary team. Adherence was strong, with 73% of participants completing five or more sessions.
Key Takeaways:
Why it matters: For the many patients who survive ICU stays each year, post-discharge recovery remains a significant challenge. This trial suggests remote rehab can make a meaningful difference — particularly over the longer term — and points to a scalable, patient-centered model worth further development.
